Le Lézard
Classified in: Health

Interim HealthCare Inc. Ranks Among 2018 Largest U.S. Healthcare Staffing Firms and Per Diem Lists by Staffing Industry Analysts


SUNRISE, Fla., Sept. 18, 2018 /PRNewswire-PRWeb/ -- Interim HealthCare Inc., a leading national franchisor of home care, hospice and healthcare staffing, was named to Staffing Industry Analysts (SIA) 2018 Largest Healthcare Staffing Firms and Largest Per Diem Nurse Staffing Firms lists.

SIA estimates that 43 firms generated at least $50 million in US healthcare temporary staffing revenue in 2017. Added together, these firms generated $11.3 billion in such revenue, accounting for 70% of the market. They also estimated that 32 travel nurse firms, 16 per diem nurse firms, 15 locum tenens firms and 30 allied healthcare firms generated at least $25 million in revenue in their respective healthcare skill sub-segments.

"It's an incredible honor to be included again on such a prestigious list and is truly a testament to the hard work and dedication put forth each and every day by our franchise owners and the healthcare professionals we put to work," said Larry Kraska, Interim HealthCare Inc. CEO and President. "As an organization that's been in business for over 50 years, we strive to make the perfect match between our highly qualified healthcare staff and the needs of our customers. This ranking is absolutely a reflection on our ability to do so year after year."

Staffing Industry Analysts ranked companies by revenue, according to industry custom. SIA corporate members can download the full report online. For more details about Interim HealthCare's staffing services, visit https://www.interimhealthcare.com/services/staffing.

About Interim HealthCare Inc.
Interim HealthCare Inc., founded in 1966, is a leading national franchisor of home care, hospice and healthcare staffing. It is part of Caring Brands International which also includes UK-based Bluebird Care and Australia-based Just Better Care, both well-known franchise brands in their countries. With more than 530 franchise locations in seven countries Caring Brands International is a global health care leader.

Interim HealthCare in the United States is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service. Franchisees employ nurses, therapists, aides, companions and other healthcare professionals who provide 25 million hours of home care service to 190,000 people each year, meeting a variety of home health, senior care, hospice, palliative care, pediatric care and healthcare staffing needs. For more information or to locate an Interim HealthCare office, visit http://www.interimhealthcare.com.

 

SOURCE Interim HealthCare Inc.


These press releases may also interest you

at 08:45
The "China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. This market research report provides key insights into the industry's rapid growth...

at 08:40
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024...

at 08:38
HFA Architecture + Engineering has expanded its healthcare design team with the addition of Principal and Healthcare Practice Leader Paul Sabal (AIA, ACHA, NCARB, LEED AP).  Sabal is a registered architect and interior designer with more than four...

at 08:35
NanoVibronix, Inc. ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...

at 08:35
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial...



News published on and distributed by: